Biopharma

Depemokimab Delivers Clinically Meaningful and Statisti...

01 March 2025 -- GSK plc (LSE/NYSE: GSK) today announced full results from the p...

Indivior Announces FDA Approval of Label Changes for Su...

Richmond, VA, February 24, 2025 – Indivior PLC (Nasdaq/LSE: INDV), a global lead...

Monthly News Roundup - February 2025

FDA Updates Izervay Label to Lengthen Treatment Duration for Geographic Atrophy ...

STAT+: On measles outbreak, the Trump administration’s ...

Why the Trump administration’s messaging on the Texas measles outbreak strikes s...

STAT+: Google’s new FDA clearance and Teladoc’s dreary ...

In this edition of STAT's Health Tech newsletter: Google gets an FDA clearance, ...

Switching between defense and attack - immune cells wit...

LMU researchers have shown that a particular type of immune cell acts more flexi...

STAT+: A look at the next generation in biotech venture...

The latest biotech updates, brought to you by The Readout newsletter.

GSK completes acquisition of IDRx, Inc.

GSK plc (LSE/NYSE: GSK) announced that it has completed the acquisition of IDRx,...

Designing self-destructing bacteria to make effective t...

Working toward more effective tuberculosis (TB) vaccines, researchers at Weill C...

New cancer vaccine method boosts potency and scope

Vaccines to treat cancers have been around since 2010, the first being approved ...

Antidepressants linked to faster cognitive decline in d...

New research suggests that antidepressants can accelerate cognitive decline in p...

Former director Francis Collins retires from NIH, urgin...

Francis Collins, former longtime director of the National Institutes of Health, ...

STAT+: Medicare and Medicaid agency faces compromised f...

CMS is facing employee firings, flagging morale, confusing messaging, and the sp...

Opinion: We tried to quantify the impact of abrupt PEPF...

A peer reviewer questioned the premise of our study into the potential impact of...

BioRestorative Receives FDA Fast Track Designation for ...

MELVILLE, N.Y., Feb. 20, 2025 (GLOBE NEWSWIRE) -- BioRestorative Therapies, Inc....

Emalex Biosciences’ Lead Candidate Meets Primary and Se...

CHICAGO—February 25, 2025—Emalex Biosciences announced positive topline data fro...

BlueRock Therapeutics Receives FDA Fast Track Designati...

Berlin, Germany, and Cambridge, MA, USA February 27, 2025 – Bayer AG and BlueRoc...

Natural Dior LLC Issues Voluntary Nationwide Recall of ...

Audience: Consumer Natural Dior LLC (USA) – February 25, 2025 – Natural ...

One in Six Parents Support Teens Getting Nonsurgical Co...

FRIDAY, Feb. 28, 2025 -- Few parents say their teen has asked about nonsurgical...

FDA Approves Odactra for the Treatment of House Dust Mi...

February 27, 2025 -- ALK (ALKB:DC / OMX: ALK B) today announced that the US Food...

FDA Roundup: February 28, 2025

The U.S. Food and Drug Administration is providing an at-a-glance summary of new...

2025 STAT Madness

2025 bracket Welcome to STAT Madness, a bracket-style contest to find the best i...

Apellis warns of Q1 growth speed bump, touts TV adverti...

During a quarterly conference call, as Apellis Pharmaceuticals discussed its pla...

Trump HHS reevaluating Biden administration's $590M bir...

The Department of Health and Human Services is reevaluating a $590 million contr...

This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies.